FLUCELVAX® (Influenza Vaccine) | CSL Seqirus flu360
FLUAD is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. FLUAD is approved for use in adults 65 years of age and older.
CSL Seqirus Portfolio | Flu Vaccines | CSL Seqirus flu360
The CSL Seqirus vaccine portfolio is dedicated to both innovative and well-established influenza technologies. Discover our portfolio of quadrivalent flu vaccines at flu360.com.
flu360® Influenza Vaccine Business & Healthcare Solutions | CSL …
CSL Seqirus understands the complexities of managing flu vaccinations. When you sign up with flu360, you gain a dedicated partner, expert vaccination support and service, and access to CSL Seqirus' differentiated flu vaccine portfolio.
FLUAD® (Influenza Vaccine, Adjuvanted) for 65+ | CSL Seqirus …
FLUAD® with MF59® Adjuvant is a flu vaccine designed to strengthen, broaden, and lengthen the duration of the immune response and is approved for patients 65+. Visit flu360.com to learn more.
Account Login | CSL Seqirus flu360
Manufactured by: Seqirus Inc., 475 Green Oaks Parkway, Holly Springs, NC 27540, USA Distributed by: Seqirus USA Inc., 25 Deforest Avenue, Summit, NJ, 07901, USA ©2024 Seqirus USA Inc. May 2024 USA-FLU360-24-0056, USA-FLU360-24-0057, USA-FLU360-24-0058
AFLURIA® (Influenza Vaccine) | CSL Seqirus flu360
AFLURIA is an inactivated influenza vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine. AFLURIA is approved for use in persons 6 months of age and older.
Influenza Vaccination Resources for Healthcare Professionals | CSL ...
flu360® provides the information and guidance needed during the flu season and beyond. Take advantage of the latest influenza vaccine resources and solutions available from flu360.
CSL Seqirus offers a wide range of influenza vaccines for patients 6 months to 65 years of age and older. For US Healthcare Professional Use Only This information does not constitute a guarantee or warranty of coverage benefits or reimbursement.
Coding and Billing Information | CSL Seqirus flu360
90658=Influenza vaccine, trivalent (IIV3), split virus, 0.5-mL dosage, for intramuscular use b No more than 10 doses (0.25 mL or 0.5 mL) should be withdrawn from the AFLURIA multi-dose vial. Download AFLURIA® Guide for more vaccine-specific details
Flu Vaccine Return FAQ | CSL Seqirus flu360
Get more information about CSL Seqirus flu vaccine returns and learn how to submit a return for our products with the help of these frequently asked questions.